News
Results from the first part of a Phase I/II trial (NCT06569823) showed that Z-1018 generated immune responses comparable to ...
This explainer unpacks how recent US policy shifts are reshaping diversity, equity, and inclusion in clinical research, ...
In this video interview, Caroline Potts, general manager of sites and patient services at Medical Research Network (MRN), ...
A new exploratory study will evaluate the safety of Anktiva in patients with long COVID, with secondary and exploratory ...
The Supreme Court has ruled 5-4 to allow the Trump administration’s NIH funding cuts to continue, impacting more than 1,700 medical research grants in areas including heart disease, HIV/AIDS, ...
With approval to proceed, the Phase II trial (NCT06092034) of RP-A501 for Danon disease restarts under an optimized dosing ...
Results from the Phase II OptiTROP-Lung01 trial (NCT05351788) showed that Sichuan Kelun-Biotech’s sac-TMT combined with ...
In this video interview, Caroline Potts, general manager of sites and patient services at Medical Research Network (MRN), ...
An overview of how recent funding reductions are reshaping clinical trial operations, from site sustainability and patient ...
In this episode of the Applied Clinical Trials Brief, we spotlight a recent video interview in which Jon Walsh, founder and ...
In this episode of the Applied Clinical Trials Brief, we recap our three most-viewed articles of the week—featuring updated ...
Results from the Phase II COLLECTiVE202 trial (NCT05370885) demonstrated a statistically significant difference between VE202 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback